Phase II efficacy results using an oncolytic herpes simplex virus (NV1020) in patients with colorectal cancer metastatic to liver (mCRC) 45th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) Geevarghese, S. K., Chen, A., Geller, D. A., de Haan, H. A., Iagaru, A., Knoll, A., Nemunaitis, J., Reid, T. R., Sze, D. Y., Tanabe, K. AMER SOC CLINICAL ONCOLOGY. 2009

View details for Web of Science ID 000276606601031